AntriaBio Announces $13 Million Close Of Private Placement Transaction And Plan To Dose First Patient With AB101 This Month Post author:Sam Post published:July 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Teva's CGRP Migraine Med Hits a Stumbling Block February 8, 2018 Pressure BioSciences, Inc. Achieves CE Marking For Its Next Generation Sample Preparation Instrument, The Barocycler 2320EXTREME February 1, 2017 Achaogen COO Promoted to Top Post, Effective Jan. 1, 2018 December 11, 2017
Pressure BioSciences, Inc. Achieves CE Marking For Its Next Generation Sample Preparation Instrument, The Barocycler 2320EXTREME February 1, 2017